CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 69  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.1015
LYS 10.0537
GLU 20.0481
LEU 30.0309
ARG 40.0315
CYS 50.0240
GLN 60.0346
CYS 70.0231
ILE 80.1015
LYS 90.0983
THR 100.0293
TYR 110.0125
SER 120.0130
LYS 130.0393
PRO 140.0224
PHE 150.0122
HIS 160.0060
PRO 170.0067
LYS 180.0107
PHE 190.0047
ILE 200.0073
LYS 210.0086
GLU 220.0127
LEU 230.0172
ARG 240.0227
VAL 250.0140
ILE 260.0189
GLU 270.0246
SER 280.0130
GLY 290.0216
PRO 300.0134
HIS 310.0231
CYS 320.0344
ALA 330.0447
ASN 340.0498
THR 350.0147
GLU 360.0100
ILE 370.0150
ILE 380.0196
VAL 390.0149
LYS 400.0094
LEU 410.0088
SER 420.0050
ASP 430.0117
GLY 440.0115
ARG 450.0113
GLU 460.0246
LEU 470.0269
CYS 480.0224
LEU 490.0086
ASP 500.0140
PRO 510.0206
LYS 520.0227
GLU 530.0139
ASN 540.0075
TRP 550.0147
VAL 560.0130
GLN 570.0127
ARG 580.0066
VAL 590.0048
VAL 600.0061
GLU 610.0078
LYS 620.0065
PHE 630.0048
LEU 640.0141
LYS 650.0325
ARG 660.0197
ALA 670.0052
GLU 680.0260
ASN 690.0240

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.